subject: CHEBI:6931

subject_name: Midazolam

object_name: coronary artery disorder


subject: CHEBI:6931

object_name: coronary atherosclerosis

tested_intervention: yes


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: IgE responsiveness, atopic

tested_intervention: unsure


subject: UNII:420K487FSG

object_name: genetic disease


subject: UNII:420K487FSG

object_name: Skin Diseases, Eczematous


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: CHEBI:31705

subject_name: Iodixanol

object_name: Contrast media reaction


subject: CHEBI:31709

subject_name: Iohexol


subject: CHEBI:31709


subject: CHEBI:31709


subject: CHEBI:64198

subject_name: Dimercaprol

object_name: Malnutrition (calorie)


subject: PR:000015049

subject_name: long-chain fatty acid transport protein 5


subject: PR:000012301


subject: PR:000005317

subject_name: bile salt-activated lipase


subject: CHEBI:29972

subject_name: L-glutamic acid residue


subject: CHEBI:16015

subject_name: Glutamic acid


subject: CHEBI:28645

subject_name: FRUCTOSE


subject: UNII:W58CDF8S4H

subject_name: BUTYPHOS


subject: CHEBI:38737

subject_name: tribufos


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Altered Taste


subject: CHEBI:229223

subject_name: Daprodustat

object_name: allergic bronchopulmonary aspergillosis


subject: CHEBI:4445

subject_name: Desflurane

object_name: esophageal adenocarcinoma


subject: CHEBI:4445

object_name: lung adenocarcinoma


subject: CHEBI:4445

object_name: cervical adenocarcinoma


subject: CHEBI:4445

object_name: adenocarcinoma


subject: CHEBI:4445

object_name: bile duct adenocarcinoma


subject: CHEBI:4445

object_name: gastric adenocarcinoma


subject: CHEBI:4445

object_name: pancreatic neoplasm


subject: CHEBI:3374

subject_name: Capsaicin

object_name: interstitial cystitis


subject: CHEBI:3374

object_name: vulvar disease


subject: PR:000022283

subject_name: excinuclease cho

object_name: Childhood Neuroblastoma


subject: PR:000022283

object_name: neuroblastoma


subject: UniProtKB:P76213

subject_name: CHO_ECOLI Excinuclease cho (sprot)


subject: UniProtKB:P76213


subject: CHEBI:132082

subject_name: Entinostat

object_name: intraocular lymphoma


subject: CHEBI:132082

object_name: small intestine lymphoma


subject: CHEBI:132082

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:132082

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:132082

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:132082

object_name: anaplastic large cell lymphoma


subject: CHEBI:132082

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:132082

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:132082

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:132082

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:132082

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:132082

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:132082

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:132082

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:132082

object_name: splenic marginal zone lymphoma


subject: CHEBI:132082

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:132082

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:132082

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:132082

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:132082

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:132082

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:132082

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:132082

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:132082

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:132082

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:132082

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:132082

object_name: MALT lymphoma


subject: CHEBI:132082

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:132082

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:132082

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:132082

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:132082

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:132082

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:132082

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:132082

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:132082

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:132082

object_name: central nervous system non-hodgkin lymphoma


subject: CHEBI:132082

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:132082

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:132082

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:132082

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:132082

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:132082

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:132082

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:132082

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:132082

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: intraocular lymphoma


subject: CHEBI:6067

object_name: small intestine lymphoma


subject: CHEBI:6067

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:6067

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:6067

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:6067

object_name: anaplastic large cell lymphoma


subject: CHEBI:6067

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:6067

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:6067

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:6067

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:6067

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:6067

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:6067

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:6067

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:6067

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:6067

object_name: splenic marginal zone lymphoma


subject: CHEBI:6067

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:6067

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:6067

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:6067

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:6067

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:6067

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:6067

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:6067

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:6067

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:6067

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:6067

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:6067

object_name: MALT lymphoma


subject: CHEBI:6067

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:6067

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:6067

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:6067

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:6067

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:6067

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:6067

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:6067

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:6067

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:6067

object_name: central nervous system non-hodgkin lymphoma


subject: CHEBI:6067

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:6067

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:6067

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:6067

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:6067

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:6067

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:6067

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:6067

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:6067

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:32660

subject_name: asparaginase

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:32660

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:52717

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate

object_name: T-cell adult acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419

object_name: T-cell childhood acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:16760419

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:16760419

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:15640

subject_name: Leucovorin


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: DRUGBANK:DB17826

object_name: hemophilia A


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: Drug Interactions


subject: CHEBI:8228

subject_name: Pioglitazone


subject: UMLS:C0972569

subject_name: Electrophoresis Gel

object_name: periodontitis


subject: UMLS:C1382104

subject_name: Gel physical state


subject: UMLS:C1551386

subject_name: Gel - ContainerSeparator


subject: CHEBI:33349

subject_name: dubnium atom


subject: CHEBI:33357

subject_name: hassium atom


subject: CHEBI:133630

subject_name: His-Ala


subject: UniProtKB:P03456

subject_name: HEMA_I68A3 Hemagglutinin (sprot)


subject: UniProtKB:P03446

subject_name: HEMA_I76A2 Hemagglutinin (sprot)


subject: UniProtKB:A3DRP0

subject_name: HEMA_I96A2 Hemagglutinin (sprot)


subject: UniProtKB:A4K143

subject_name: HEMA_I54A2 Hemagglutinin (sprot)


subject: UniProtKB:B4URD6

subject_name: HEMA_I06A0 Hemagglutinin (sprot)


subject: UniProtKB:Q0A448

subject_name: hemagglutinin (Influenza A virus (strain A/Duck/Germany/1949 H10N7))


subject: UMLS:C4285347

subject_name: Ha Antibody


subject: UniProtKB:Q9WCD8

subject_name: HEMA_I61A1 Hemagglutinin (sprot)


subject: UniProtKB:P03453

subject_name: HEMA_I77AB Hemagglutinin (sprot)


subject: UniProtKB:A4U7A6

subject_name: HEMA_I51A0 Hemagglutinin (sprot)


subject: UniProtKB:P13103

subject_name: HEMA_I77AF Hemagglutinin (sprot)


subject: UniProtKB:P26136

subject_name: HEMA_I82A1 Hemagglutinin (sprot)


subject: UniProtKB:P07976

subject_name: HEMA_I83A5 Hemagglutinin (sprot)


subject: UniProtKB:A4GBX7

subject_name: HEMA_I77AA Hemagglutinin (sprot)


subject: UniProtKB:P19698

subject_name: HEMA_I79A7 Hemagglutinin (sprot)


subject: UniProtKB:Q6LEJ4

subject_name: HEMA_I80A2 Hemagglutinin (sprot)


subject: UniProtKB:P03457

subject_name: HEMA_I66A1 Hemagglutinin (sprot)


subject: UniProtKB:A4GCL9

subject_name: HEMA_I35A3 Hemagglutinin (sprot)


subject: UniProtKB:Q9WFX3

subject_name: HEMA_I18A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U6V2

subject_name: HEMA_I45A0 Hemagglutinin (sprot)


subject: UniProtKB:Q07FI5

subject_name: HEMA_I96A3 Hemagglutinin (sprot)


subject: UniProtKB:P03454

subject_name: HEMA_I33A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCK8

subject_name: HEMA_I43A0 Hemagglutinin (sprot)


subject: UniProtKB:P03448

subject_name: HEMA_I72A5 Hemagglutinin (sprot)


subject: UniProtKB:A4GCI6

subject_name: HEMA_I36A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCJ7

subject_name: HEMA_I80AA Hemagglutinin (sprot)


subject: UniProtKB:P04661

subject_name: HEMA_I56A2 Hemagglutinin (sprot)


subject: UniProtKB:Q0HD60

subject_name: HEMA_I40A0 Hemagglutinin (sprot)


subject: UniProtKB:P26139

subject_name: HEMA_I77A4 Hemagglutinin (sprot)


subject: UniProtKB:A4GCH5

subject_name: HEMA_I83A1 Hemagglutinin (sprot)


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Disuse osteoporosis


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UNII:3593C180JO

object_name: hepatitis C


subject: UMLS:C3251932


subject: UMLS:C3540795

subject_name: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UMLS:C3540795

object_name: malignant neoplasm of breast stage I


subject: UMLS:C3540795

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C3540795

object_name: Carcinoma breast stage I


subject: PUBCHEM.COMPOUND:49800030

subject_name: METHYLPREDNISOLONE ACETATE

object_name: migraine


subject: PUBCHEM.COMPOUND:49800030

object_name: migraine with or without aura, susceptibility to, 1


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate


subject: PUBCHEM.COMPOUND:584547


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: MESH:C469610

object_name: COVID-19 respiratory infection


subject: MESH:C469610

object_name: Pneumonia caused by SARS-CoV-2


subject: MESH:C469610

object_name: Acute respiratory distress syndrome due to COVID-19


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: pharyngitis


subject: CHEBI:26710

object_name: Pharyngalgia


subject: CHEBI:26710

object_name: Sore Throat, CTCAE


subject: CHEBI:23965

subject_name: estradiol

object_name: Constitutional tall stature


subject: PUBCHEM.COMPOUND:22896913

subject_name: Ioflupane

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: PUBCHEM.COMPOUND:22896913

object_name: amyotrophic lateral sclerosis


subject: UMLS:C1684399


subject: UMLS:C1684399


subject: CHEBI:68855

subject_name: Ioflupane I-123


subject: CHEBI:68855


subject: UMLS:C2980484

subject_name: DaTscan


subject: UMLS:C2980484


subject: CHEBI:7553

subject_name: Niclosamide

object_name: diabetic kidney disease


subject: UMLS:C2981842

object_name: pyoderma gangrenosum


subject: CHEBI:18358

subject_name: Methoxsalen

object_name: rheumatoid arthritis


subject: CHEBI:101278

subject_name: Diltiazem

object_name: Atrial fibrillation and flutter


subject: PUBCHEM.COMPOUND:73357808

subject_name: Flutiform

object_name: asthma


subject: UMLS:C4742201

subject_name: flutiform


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Disease Exacerbation


subject: PUBCHEM.COMPOUND:5281099

subject_name: Natamycin

object_name: Genital Vulvovaginal Candidiasis


subject: PUBCHEM.COMPOUND:4283516

subject_name: pimaricin


subject: CHEBI:31515

subject_name: Domperidone

object_name: Edema Limbs


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol

object_name: osteomyelitis


subject: UNII:CLH5FT6412

object_name: Osteosarcoma


subject: UNII:CLH5FT6412

object_name: bone sarcoma


subject: UNII:CLH5FT6412

object_name: pediatric osteosarcoma


subject: UNII:CLH5FT6412

object_name: Ewing sarcoma


subject: UNII:CLH5FT6412

object_name: bone chondrosarcoma


subject: UNII:CLH5FT6412

object_name: chondrosarcoma


subject: UNII:CLH5FT6412

object_name: Adult Rhabdomyosarcoma


subject: UNII:CLH5FT6412

object_name: rhabdomyosarcoma


subject: UNII:CLH5FT6412

object_name: Childhood Rhabdomyosarcoma


subject: UNII:CLH5FT6412

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:CLH5FT6412

object_name: bone cancer


subject: UNII:CLH5FT6412

object_name: osteonecrosis


subject: UNII:CLH5FT6412

object_name: avascular necrosis


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Transthyretin cardiac amyloidosis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:12443252

subject_name: Tauroursodeoxycholic acid


subject: CHEBI:80774

subject_name: taurursodiol


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: primary focal segmental glomerulosclerosis


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: acute pain due to trauma


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: CHEBI:94295

subject_name: Darinaparsin

object_name: bone marrow neoplasm


subject: CHEBI:94295

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:94295

object_name: non-Hodgkin lymphoma


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Ultrafiltration failure


subject: UNII:D92HH8C8ES

subject_name: LACTOBACILLUS ACIDOPHILUS L-92

object_name: Atopic rhinitis


subject: UNII:D92HH8C8ES

object_name: Hay fever


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Squamous cell carcinoma of head and neck recurrent


subject: PUBCHEM.COMPOUND:131769963

object_name: Squamous cell carcinoma of head and neck metastatic


subject: PUBCHEM.COMPOUND:131769963

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: PUBCHEM.COMPOUND:131769963

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: PUBCHEM.COMPOUND:131769963

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: disseminated eosinophilic collagen disease


subject: CHEBI:182913

object_name: Eosinophilia


subject: CHEBI:182913

object_name: idiopathic hypereosinophilic syndrome


subject: CHEBI:8356

subject_name: Pramipexole


subject: CHEBI:8356


subject: CHEBI:8356


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: glioblastoma


subject: UNII:2Y3T5IF01Z

object_name: Brain Stem Glioblastoma


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: CHEBI:180664

subject_name: Tempol


subject: CHEBI:6706

subject_name: Mecamylamine

object_name: Cancer patients and suicide and depression


subject: CHEBI:6706

object_name: Depressed - symptom


subject: CHEBI:6706

object_name: Depression, CTCAE


subject: UMLS:C1170374

subject_name: Lipidil Supra

object_name: inherited lipid metabolism disorder


subject: UMLS:C1170374

object_name: Dyslipidemia


subject: UMLS:C1815093

subject_name: Coreg CR

object_name: Childhood Breast Carcinoma


subject: UMLS:C1815093

object_name: breast carcinoma


subject: UMLS:C1815093

object_name: breast cancer


subject: UMLS:C1815093

object_name: cardiotoxicity


subject: CHEBI:6503

subject_name: LISINOPRIL


subject: CHEBI:6503


subject: CHEBI:6503


subject: CHEBI:6503


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: CHEBI:43755


subject: CHEBI:43755


subject: PUBCHEM.COMPOUND:184196

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:184196

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:184196

object_name: Childhood Rectal Carcinoma


subject: UMLS:C4048807


subject: UMLS:C4048807


subject: UMLS:C4048807


subject: UMLS:C3827100

subject_name: c-Met Inhibitor MSC2156119J

object_name: Solid Neoplasm


subject: UMLS:C1875126

subject_name: ESTROGENS,VAGINAL

object_name: Urinary Urgency


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: neoplasm


subject: UNII:B2K5L1L8S9

object_name: Tumor Mass


subject: CHEBI:36121

subject_name: flavylium

object_name: Postprandial hyperglycemia


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: chronic kidney disease


subject: CHEBI:82977

subject_name: Daclatasvir


subject: PR:000034142

subject_name: CRISPR system Cascade subunit CasE

object_name: ankyloglossia


subject: UMLS:C4053581

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C4053581

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C4053581

object_name: sarcoma


subject: UMLS:C4053581

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4053581

object_name: soft tissue sarcoma


subject: CHEMBL.COMPOUND:CHEMBL5314366

subject_name: ESOMEPRAZOLE MAGNESIUM

object_name: Barrett esophagus


subject: CHEBI:91327

subject_name: Tivozanib

object_name: Unresectable Hepatocellular Carcinoma


subject: CHEBI:91327

object_name: Advanced Adult Hepatocellular Carcinoma


subject: UMLS:C1739076

object_name: non-small cell lung carcinoma


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: type 1 diabetes mellitus


subject: CHEBI:139608

subject_name: sepantronium bromide


subject: CHEBI:139608

object_name: prostate carcinoma


subject: CHEBI:139608

object_name: prostate cancer


subject: UMLS:C2002939

object_name: neoplasm


subject: CHEBI:6931

subject_name: Midazolam

object_name: metastatic prostate carcinoma


subject: UMLS:C4745035

subject_name: CYP11A1 inhibitor ODM-208


subject: CHEBI:93109

subject_name: Semaxanib

object_name: colorectal cancer


subject: CHEBI:93109

object_name: colorectal carcinoma


subject: CHEBI:93109

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:91083

subject_name: Romiplostim


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:53762

object_name: major depressive disorder


subject: CHEBI:32315

subject_name: Zopiclone


subject: CHEBI:4453

subject_name: Desogestrel

object_name: Uses contraception (finding)


subject: UMLS:C4054493

subject_name: Mimotope-P10s-PADRE Peptide Vaccine

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4054493

object_name: Embolism, Tumor


subject: UMLS:C4054493

object_name: Neoplasm Metastasis


subject: UMLS:C4054493

object_name: cancer


subject: CHEBI:32599

object_name: pelvic pain on the left


subject: CHEBI:32599

object_name: pelvic pain occurs with urination


subject: CHEBI:32599

object_name: pelvic pain occurs with bowel movement


subject: CHEBI:32599

object_name: pelvic pain decreasing in severity


subject: CHEBI:32599

object_name: Pelvic pain female


subject: CHEBI:32599

object_name: pelvic pain increasing in severity


subject: CHEBI:32599

object_name: male pelvic pain


subject: CHEBI:32599

object_name: pelvic pain to the rear


subject: CHEBI:32599

object_name: pelvic pain on the right


subject: CHEBI:32599

object_name: pelvic pain decreasing in frequency


subject: CHEBI:32599

object_name: Pelvic pain


subject: CHEBI:32599

object_name: Pelvic Pain, CTCAE 5.0


subject: CHEBI:32599

object_name: pelvic pain causes awakening at night


subject: CHEBI:32599

object_name: pelvic pain increasing in frequency


subject: CHEBI:32599

object_name: pelvic pain occurs with intercourse


subject: CHEBI:32599

object_name: pelvic pain in front


subject: CHEBI:28976

subject_name: carbonic acid


subject: CHEBI:28976


subject: CHEBI:28976


subject: CHEBI:28976


subject: CHEBI:28976


subject: CHEBI:28976


subject: CHEBI:28976


subject: CHEBI:28976


subject: CHEBI:28976


subject: CHEBI:28976


subject: CHEBI:28976


subject: CHEBI:28976


subject: CHEBI:28976


subject: CHEBI:28976


subject: CHEBI:28976


subject: CHEBI:28976


subject: UMLS:C2722820

subject_name: Bicarbonate preparation


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: MESH:D001639

subject_name: Bicarbonates


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: MESH:D001639


subject: CHEBI:17544

subject_name: Bicarbonate Ion


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:90227

subject_name: Selumetinib

object_name: Metastatic Thyroid Gland Carcinoma


subject: CHEBI:90227

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:90227

object_name: poorly differentiated thyroid gland carcinoma


subject: CHEBI:90227

object_name: Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:90227

object_name: Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:90227

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:90227

object_name: Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:90227

object_name: Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:90227

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:90227

object_name: Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:90227

object_name: Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:9356

subject_name: Sultopride

object_name: post operative nausea and vomiting


subject: UNII:8Z28M5SX0X

subject_name: Zandelisib

object_name: Follicular lymphoma refractory


subject: CHEBI:6843

subject_name: Methoxyflurane

object_name: Testicular Hematocele


subject: CHEBI:6843

object_name: Hydrocele male


subject: CHEBI:6843

object_name: scrotal disorder


subject: CHEBI:6843

object_name: spermatocele


subject: CHEBI:6843

object_name: Spermatocele


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Clonal Cytopenia of Undetermined Significance


subject: PUBCHEM.COMPOUND:5281767

object_name: essential thrombocythemia


subject: PUBCHEM.COMPOUND:5281767

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:5281767

object_name: acquired polycythemia vera


subject: CHEBI:65737

subject_name: demethoxycurcumin


subject: CHEBI:65737

object_name: Myelodysplasia


subject: CHEBI:65737

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:65737

object_name: childhood myelodysplastic syndrome


subject: CHEBI:65737

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:65737


subject: CHEBI:65737


subject: CHEBI:65737


subject: UMLS:C1508865

subject_name: Injection, omalizumab, 5 mg administered

object_name: chronic idiopathic urticaria


subject: UMLS:C5400804

subject_name: TTR Stabilizer AG10

object_name: Cardiac amyloidosis


subject: UNII:Q830PW7520

subject_name: CODEINE

object_name: Acute Pain


subject: PUBCHEM.COMPOUND:2828


subject: CHEBI:57871


subject: CHEBI:16714

subject_name: Codeine


subject: CHEBI:63631

subject_name: Topiramate

object_name: bulimia nervosa


subject: UMLS:C3640131

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C3640131

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C3640131

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UMLS:C3640131

object_name: Refractory Pancreatic Carcinoma


subject: UMLS:C3640131

object_name: Stage IIIC Prostate Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage IIIB Prostate Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage IIIA Prostate Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage IVA Prostate Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage III Prostate Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage III Ovarian Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: UMLS:C3640131

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C3640131

object_name: Refractory Ovarian Carcinoma


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: Hyperalgesia, Secondary


subject: UMLS:C0279328

object_name: Inflammation


subject: CHEBI:172944

subject_name: Cabotegravir

object_name: outcomes general quality of life


subject: CHEBI:172944

object_name: Perceived quality of life


subject: CHEBI:172944

object_name: Good quality of life


subject: CHEBI:9398

subject_name: Tamsulosin


subject: CHEBI:9398


subject: CHEBI:9398


subject: CHEBI:9398

object_name: ureteral obstruction


subject: CHEBI:9398

object_name: Ureter Obstruction, CTCAE


subject: UNII:2QN49PWH71

subject_name: benzylmandelate

object_name: ureterolithiasis


subject: UNII:2QN49PWH71


subject: UNII:2QN49PWH71


subject: UNII:2QN49PWH71


subject: UNII:2QN49PWH71


subject: UNII:2QN49PWH71


subject: PUBCHEM.COMPOUND:5284632

subject_name: Trospium


subject: PUBCHEM.COMPOUND:5284632


subject: PUBCHEM.COMPOUND:5284632


subject: PUBCHEM.COMPOUND:5284632


subject: PUBCHEM.COMPOUND:5284632


subject: PUBCHEM.COMPOUND:5284632


subject: UNII:R30772KCU0

subject_name: Isatuximab

object_name: Relapse multiple myeloma


subject: UMLS:C2983777


subject: CHEBI:90227

subject_name: Selumetinib

object_name: optic nerve glioma


subject: CHEBI:29354

subject_name: oxy group

object_name: Atopic rhinitis


subject: CHEBI:29354

object_name: Hay fever


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Chronic kidney disease stage 5 on dialysis


subject: CHEBI:60802

object_name: end stage renal failure


subject: CHEBI:60802

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:11217464

subject_name: HYDROXYTYROSOL

object_name: inborn mitochondrial metabolism disorder


subject: PUBCHEM.COMPOUND:11217464

object_name: mitochondrial disease


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:61080

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:61080

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:61080

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:61080

object_name: Adult Gliosarcoma


subject: UMLS:C4082795

subject_name: Depsipeptide Antineoplastic Antibiotic


subject: UMLS:C4082795


subject: UMLS:C4082795


subject: UMLS:C4082795


subject: UMLS:C4082795


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: UMLS:C0796678

subject_name: Depsipeptides


subject: UMLS:C0796678


subject: UMLS:C0796678


subject: UMLS:C0796678


subject: UMLS:C0796678


subject: UMLS:C0694951

subject_name: INJECTION, AMPHOTERICIN B, 50 MG ADMINISTERED

object_name: oral candidiasis


subject: UMLS:C0694951

object_name: HIV infection


subject: CHEBI:2682

subject_name: Amphotericin B


subject: CHEBI:2682


subject: CHEBI:73275

subject_name: Ospemifene

object_name: Female sexual arousal disorder


subject: CHEBI:73275

object_name: Vulvovaginal signs and symptoms


subject: CHEBI:73275

object_name: Genitourinary syndrome of menopause


subject: CHEBI:34741

subject_name: Equol

object_name: Childhood Breast Carcinoma


subject: CHEBI:34741

object_name: breast carcinoma


subject: CHEBI:34741

object_name: breast cancer


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: kidney failure


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: UMLS:C4763757

subject_name: Erfonrilimab

object_name: liver carcinoma


subject: UMLS:C4763757

object_name: Klatskin Tumor


subject: CHEBI:35480

subject_name: analgesic


subject: CHEBI:35480


subject: CHEBI:35480


subject: UMLS:C4722089

subject_name: Analgesics [TC]


subject: UMLS:C4722089


subject: UMLS:C4722089


subject: CHEBI:31632

subject_name: Decasodium salt

object_name: venous thromboembolism


subject: UMLS:C1145196

subject_name: INJECTION, FONDAPARINUX SODIUM, 0.5 MG ADMINISTERED


subject: CHEBI:28364

subject_name: Icosapent

object_name: amyloidosis, hereditary systemic 1


subject: CHEBI:37144

subject_name: epichlorohydrin

object_name: classic familial adenomatous polyposis


subject: CHEBI:37144

object_name: Adenomatous colonic polyposis


subject: CHEBI:37144


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: PR:000016352


subject: PR:000016352


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: cluster headache syndrome


subject: CHEBI:63631

subject_name: Topiramate

object_name: schizoaffective disorder


subject: UMLS:C5203927

subject_name: Oncolytic Adenovirus CAdVEC

object_name: Childhood Solid Neoplasm


subject: UMLS:C5203927

object_name: Adult Solid Neoplasm


subject: UMLS:C5203927

object_name: Solid Neoplasm


subject: UMLS:C5203927

object_name: Stomach cancer


subject: UMLS:C5203927

object_name: gastric cancer


subject: UMLS:C5203927

object_name: bladder tumor


subject: UMLS:C5203927

object_name: urinary bladder carcinoma


subject: UMLS:C5203927

object_name: urinary bladder cancer


subject: UMLS:C5203927

object_name: childhood bladder carcinoma


subject: UMLS:C5203927

object_name: salivary gland cancer


subject: UMLS:C5203927

object_name: Childhood Breast Carcinoma


subject: UMLS:C5203927

object_name: breast carcinoma


subject: UMLS:C5203927

object_name: breast cancer


subject: UMLS:C5203927

object_name: lung cancer


subject: UMLS:C5203927

object_name: lung neoplasm


subject: UMLS:C5203927

object_name: lung carcinoma


subject: UMLS:C5203927

object_name: carcinoma of esophagus


subject: UMLS:C5203927

object_name: esophageal cancer


subject: UMLS:C5203927

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5203927

object_name: neoplasm of esophagus


subject: UMLS:C5203927

object_name: colorectal cancer


subject: UMLS:C5203927

object_name: colorectal carcinoma


subject: UMLS:C5203927

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5203927

object_name: pancreatic adenocarcinoma


subject: UMLS:C5203927

object_name: head and neck squamous cell carcinoma


subject: CHEBI:78320

subject_name: Lactic acid

object_name: traumatic encephalopathy


subject: CHEBI:78320

object_name: traumatic brain injury


subject: UMLS:C1176295

subject_name: Natrium lacticum, Homeopathic preparation


subject: UMLS:C1176295


subject: UMLS:C0445115

subject_name: Normal saline

object_name: dehydration (Na, H2O)


subject: UMLS:C0445115

object_name: Dehydration, CTCAE


subject: UMLS:C0445115

object_name: Dehydration


subject: UMLS:C5785786

subject_name: 3-bromopyruvate-based Agent KAT-101

object_name: liver carcinoma


subject: UMLS:C5785786

object_name: fibrolamellar hepatocellular carcinoma


subject: UMLS:C5785785

subject_name: 3-bromopyruvate-based Agent KAT-201


subject: UMLS:C5785785


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: pneumonitis


subject: CHEBI:5801

object_name: Pneumonitis, CTCAE


subject: UNII:G6UF363ECX

object_name: Adenocarcinoma of the prostate recurrent


subject: UMLS:C4308025

subject_name: AAA 617


subject: UNII:38RL9AE51Q

subject_name: Anifrolumab

object_name: dermatomyositis


subject: UMLS:C5140447

subject_name: Sargramostim for Injection

object_name: complete trisomy 21


subject: UMLS:C5140447

object_name: Down syndrome


subject: UNII:S1W5KTD68Y

subject_name: Active Hexose Correlated Compound

object_name: Sepsis


subject: UNII:S1W5KTD68Y

object_name: Sepsis, CTCAE


subject: UMLS:C5557556

subject_name: AHCC


subject: UMLS:C5557556


subject: UNII:VK8XA79JA3

subject_name: BIFIDOBACTERIUM LONGUM BB536


subject: UNII:VK8XA79JA3


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Locally Recurrent Head and Neck Squamous Cell Carcinoma


subject: CHEBI:72317

object_name: metastatic melanoma


subject: CHEBI:72317

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:72317

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:72317

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:72317

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:72317

object_name: Unresectable Melanoma


subject: CHEBI:72317

object_name: Locally Recurrent Laryngeal Squamous Cell Carcinoma


subject: CHEBI:72317

object_name: Locally Recurrent Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:72317

object_name: Locally Recurrent Oropharyngeal Squamous Cell Carcinoma


subject: CHEBI:72317

object_name: Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma


subject: CHEBI:72317

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:72317

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:72317

object_name: Stage III Laryngeal Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:72317

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:72317

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:72317

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Locally Recurrent Head and Neck Squamous Cell Carcinoma


subject: CHEBI:231614

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:231614

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:231614

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:231614

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:231614

object_name: Locally Recurrent Laryngeal Squamous Cell Carcinoma


subject: CHEBI:231614

object_name: Locally Recurrent Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:231614

object_name: Locally Recurrent Oropharyngeal Squamous Cell Carcinoma


subject: CHEBI:231614

object_name: Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma


subject: CHEBI:231614

object_name: Stage III Laryngeal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:231614

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C2346820

object_name: Locally Recurrent Head and Neck Squamous Cell Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UMLS:C2346820

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C2346820

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UMLS:C2346820

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UMLS:C2346820

object_name: Locally Recurrent Laryngeal Squamous Cell Carcinoma


subject: UMLS:C2346820

object_name: Locally Recurrent Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C2346820

object_name: Locally Recurrent Oropharyngeal Squamous Cell Carcinoma


subject: UMLS:C2346820

object_name: Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma


subject: UMLS:C2346820

object_name: Stage III Laryngeal Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: UMLS:C2346820

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: UMLS:C2346820

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C2346820

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UMLS:C2346820

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UMLS:C2346820

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C2346820

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C1553426

subject_name: Boric Acid - Specimen Additive

object_name: bacterial vaginosis


subject: CHEBI:33118

subject_name: Boric acid


subject: UMLS:C1161318

subject_name: Boric acidum, boric acid, Homeopathic preparation


subject: UMLS:C0038818

subject_name: Sunscreening Agents

object_name: skin neoplasm


subject: UMLS:C0038818

object_name: skin cancer


subject: PR:000011400

subject_name: nuclear receptor subfamily 2 group C member 2

object_name: asthma


subject: PR:000004649

subject_name: large proline-rich protein BAT2

object_name: respiratory syncytial virus infectious disease


subject: PR:000031921

subject_name: protein PBMUCL2


subject: UniProtKB:E2RYF7

subject_name: PBMU2_HUMAN Protein PBMUCL2 (sprot)


subject: UMLS:C0165193


subject: UMLS:C3493856

object_name: Inflammation


subject: UMLS:C3493856

object_name: rheumatoid arthritis


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Nail-biting


subject: CHEBI:7421

subject_name: NAC


subject: UMLS:C5774060

subject_name: Prurisol

object_name: Chronic small plaque psoriasis


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: Inhalation injury


subject: UMLS:C2825026

object_name: Burn injury


subject: CHEBI:151315

subject_name: Heparin


subject: UMLS:C1831769

object_name: cancer


subject: UMLS:C1831769

object_name: neoplasm


subject: CHEBI:233453

object_name: encephalitis


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:50730

subject_name: Montelukast

object_name: obstructive sleep apnea syndrome


subject: CHEBI:49165


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Post-polycythemia vera myelofibrosis


subject: UNII:28X28X9OKV

object_name: myelofibrosis


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:50790

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:50790

object_name: stage IA breast cancer


subject: CHEBI:50790

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:50790

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:50790

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:50790

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:50790

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:50790

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:50790

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:50790

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:50790

object_name: HER2/Neu Negative


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: Stage IB Breast Cancer AJCC v7


subject: UMLS:C0593802

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: Stage IA Breast Cancer AJCC v7


subject: UMLS:C0593802

object_name: stage IA breast cancer


subject: UMLS:C0593802

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: Stage IIB Breast Carcinoma


subject: UMLS:C0593802

object_name: malignant neoplasm of breast stage IIb


subject: UMLS:C0593802

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: Stage IIA Breast Carcinoma


subject: UMLS:C0593802

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C0593802

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C0593802

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C0593802

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C0593802

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0593802

object_name: HER2/Neu Negative


subject: CHEBI:91951

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:91951

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:91951

object_name: stage IA breast cancer


subject: CHEBI:91951

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:91951

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:91951

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:85993

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:85993

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:85993

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:28240

subject_name: dichloroacetate

object_name: pyruvate dehydrogenase E1-alpha deficiency


subject: CHEBI:28240

object_name: pyruvate dehydrogenase deficiency


subject: CHEBI:28240

object_name: Decreased activity of the pyruvate dehydrogenase complex


subject: CHEBI:36386

subject_name: Dichloroacetic acid


subject: CHEBI:36386


subject: CHEBI:36386


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Periodic limb movement sleep disorder


subject: CHEBI:75832

object_name: sleep disorder


subject: CHEBI:50730

object_name: Parkinson disease


subject: CHEBI:25187

subject_name: Menthol

object_name: chronic obstructive pulmonary disease


subject: MESH:D004338

subject_name: Drug Combinations

object_name: plasmacytoma


subject: MESH:D004338

object_name: Relapse multiple myeloma


subject: MESH:D004338

object_name: Plasma cell myeloma recurrent


subject: UMLS:C0013162


subject: UMLS:C0013162


subject: UMLS:C0013162


subject: GTOPDB:9802

object_name: rheumatoid arthritis


subject: UMLS:C4548814


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: inherited lipid metabolism disorder


subject: UNII:LKC0U3A8NJ

object_name: Dyslipidemia


subject: CHEBI:60654

subject_name: valproate

object_name: childhood ependymoma


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:39867

subject_name: Valproic acid


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:6801

subject_name: Metformin

object_name: carcinoma


subject: CHEBI:6801

object_name: rectal neoplasm


subject: UMLS:C5706515

subject_name: CDK2/4/6 Inhibitor RGT-419B

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5706515

object_name: Childhood Breast Carcinoma


subject: UMLS:C5706515

object_name: breast carcinoma


subject: UMLS:C5706515

object_name: breast cancer


subject: UMLS:C0093142

object_name: atrial fibrillation


subject: UMLS:C0093142

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C0093142

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:17026

subject_name: Progesterone

object_name: brain injury


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:58097

object_name: rotator cuff syndrome


subject: CHEBI:58097

object_name: Rotator cuff tear


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:7454

subject_name: Nalbuphine


subject: CHEBI:7454


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Her2-receptor negative breast cancer


subject: GTOPDB:9758

object_name: Homologous Recombination Repair Gene Mutation


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C1384659

object_name: colorectal cancer


subject: UMLS:C1384659

object_name: colorectal carcinoma


subject: UMLS:C1384659

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1701110

subject_name: Zactima


subject: UMLS:C1701110


subject: UMLS:C1701110


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:75551


subject: MESH:D004043

subject_name: Dietary Fiber

object_name: type 2 diabetes mellitus


subject: CHEBI:201441

subject_name: GATIFLOXACIN

object_name: tuberculosis


subject: CHEBI:5280

subject_name: Gatifloxacin


subject: CHEBI:4875

subject_name: Etanercept

object_name: Fanconi anemia


subject: CHEBI:4875

object_name: Fanconi anemia complementation group A


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: CHEBI:24838

subject_name: inorganic phosphate

object_name: Heart Disease Risk Factors


subject: CHEBI:18367

subject_name: Phosphate ion


subject: CHEBI:231693

subject_name: Capmatinib

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: CHEBI:231693

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:231693

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:231693

object_name: Invasive Cutaneous Melanoma


subject: CHEBI:231693

object_name: RET Fusion Positive


subject: CHEBI:231693

object_name: ROS1 Fusion Positive


subject: CHEBI:231693

object_name: NTRK3 Fusion Positive


subject: CHEBI:231693

object_name: NTRK2 Fusion Positive


subject: CHEBI:231693

object_name: NTRK1 Fusion Positive


subject: CHEBI:231693

object_name: MET Fusion Gene Positive


subject: CHEBI:231693

object_name: ALK Fusion Protein Expression


subject: CHEBI:78432

subject_name: Ceritinib


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:195558

subject_name: Entrectinib


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: anxiety disorder


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8354

subject_name: Pralidoxime

object_name: Organophosphorus Poisoning


subject: UMLS:C2114799

subject_name: promestriene vaginal

object_name: Vaginal Atrophy


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage IIA1 Cervical Cancer FIGO 2018


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIA2 Cervical Cancer FIGO 2018


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIA Cervical Cancer FIGO 2018


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVA Cervical Cancer FIGO 2018


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Cervical Cancer FIGO 2018


subject: PUBCHEM.COMPOUND:2767

object_name: Stage II Cervical Cancer FIGO 2018


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IB3 Cervical Cancer FIGO 2018


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Cervical Cancer FIGO 2018


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIB Cervical Cancer FIGO 2018


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC Cervical Cancer FIGO 2018


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC2 Cervical Cancer FIGO 2018


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIC1 Cervical Cancer FIGO 2018


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Cervical Cancer FIGO 2018


subject: CHEBI:9728

subject_name: Trimethaphan

object_name: coronary microvascular disorder


subject: UMLS:C4684972

subject_name: Microtubule Inhibitor SCB01A

object_name: Solid Neoplasm


subject: UMLS:C0950790

object_name: childhood neoplasm


subject: UMLS:C0950790

object_name: neoplastic syndrome


subject: UMLS:C0950790

object_name: cancer or benign tumor


subject: UMLS:C0950790

object_name: neoplasm


subject: CHEBI:5847

subject_name: Raltitrexed


subject: CHEBI:5847


subject: CHEBI:5847


subject: CHEBI:5847


subject: UMLS:C0878095

subject_name: Tomudex


subject: UMLS:C0878095


subject: UMLS:C0878095


subject: UMLS:C0878095


subject: PUBCHEM.COMPOUND:168009928

subject_name: Keyhole limpet hemocyanin

object_name: glioblastoma


subject: PUBCHEM.COMPOUND:168009928

object_name: Childhood Glioblastoma


subject: PUBCHEM.COMPOUND:168009928

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:168009928

object_name: glioma


subject: PUBCHEM.COMPOUND:168009928

object_name: malignant glioma


subject: UNII:FV4Y0JO2CX

subject_name: keyhole-limpet hemocyanin


subject: UNII:FV4Y0JO2CX


subject: UNII:FV4Y0JO2CX


subject: UNII:FV4Y0JO2CX


subject: UNII:FV4Y0JO2CX


subject: CHEMBL.COMPOUND:CHEMBL5314988

subject_name: KEYHOLE LIMPET HEMOCYANIN


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0599934

subject_name: Vaccines, Peptide


subject: UMLS:C0599934


subject: UMLS:C0599934


subject: UMLS:C0599934


subject: UMLS:C0599934


subject: CHEBI:37168

subject_name: iota-carrageenan

object_name: Conjunctivitis caused by adenovirus


subject: DRUGBANK:DB15304

subject_name: iota-Carrageenan


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: dilated cardiomyopathy


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: viral pneumonia


subject: CHEBI:6888

object_name: blood coagulation disease


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]


subject: UMLS:C5392628

object_name: Prediabetes


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: intracranial hypotension


subject: MESH:D012462

object_name: Decreased intracranial pressure


subject: MESH:D012462

object_name: brain edema


subject: MESH:D012462

object_name: stroke disorder


subject: MESH:D012462

object_name: cerebrovascular disorder


subject: MESH:D012462

object_name: Stroke (heart beat)


subject: MESH:D012462

object_name: Stroke, CTCAE


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: estrogen-receptor positive breast cancer


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: CHEBI:95089

subject_name: Ipatasertib


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Recurrent Indolent Adult Non-Hodgkin Lymphoma


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Aggressive Non-Hodgkin Lymphoma


subject: CHEBI:61057

object_name: Aggressive Adult Non-Hodgkin Lymphoma


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: invasive breast carcinoma


subject: UMLS:C2826229

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C2826229

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C2826229

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C2826229

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C2826229


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: MESH:C520255

object_name: stage IVA gallbladder cancer


subject: MESH:C520255

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: MESH:C520255

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: MESH:C520255

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: MESH:C520255

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v7


subject: MESH:C520255

object_name: Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7


subject: MESH:C520255

object_name: Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:84040

object_name: glucose intolerance


subject: CHEBI:84040

object_name: Impaired glucose tolerance


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:137359

object_name: Prediabetes


subject: CHEBI:137359


subject: CHEBI:137359


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid


subject: CHEBI:37084


subject: CHEBI:37084


subject: CHEMBL.COMPOUND:CHEMBL4525124

subject_name: HMB


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEBI:8212

subject_name: Pimozide

object_name: psychosis


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:72317

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:72317

object_name: stage IIIB melanoma


subject: CHEBI:72317

object_name: stage IIIA melanoma


subject: CHEBI:72317

object_name: stage IIIC melanoma


subject: CHEBI:72317

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: Melanoma recurrent


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: CHEBI:63637


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes


subject: UMLS:C5700219

object_name: Childhood Immunoblastic Lymphoma


subject: UMLS:C5700219

object_name: Childhood Diffuse Large Cell Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Childhood Large Cell Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Childhood Burkitt Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: UMLS:C5700219

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: UMLS:C5700219

object_name: Burkitt lymphoma


subject: UMLS:C5700219

object_name: Childhood Burkitt Lymphoma


subject: UMLS:C5700219

object_name: Secondary Myelodysplastic Syndrome


subject: UMLS:C2316467

subject_name: Packed red blood cells

object_name: cardiac arrest


subject: UMLS:C2316467

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:18359

subject_name: holo-[acyl-carrier protein]

object_name: rotator cuff syndrome


subject: CHEBI:18359

object_name: Rotator cuff tear


subject: CHEBI:13534

subject_name: acyl-carrier protein


subject: CHEBI:13534


subject: UMLS:C0001369

subject_name: Acyl Carrier Protein


subject: UMLS:C0001369


subject: UMLS:C0010575

subject_name: Cycloleucine


subject: UMLS:C0010575


subject: PR:000011081

subject_name: acyl carrier protein, mitochondrial


subject: PR:000011081


subject: UMLS:C5140533

subject_name: Tesamorelin for Injection

object_name: HIV infection


subject: UMLS:C4727613

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C4727613


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: pseudomyxoma peritonei


subject: UNII:3A189DH42V

object_name: Metastatic malignant neoplasm to peritoneum


subject: UNII:3A189DH42V

object_name: Metastatic malignant neoplasm to retroperitoneum


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: UMLS:C4279742

object_name: hypertension


subject: UMLS:C4279742

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:123315041

subject_name: VIBEGRON


subject: PUBCHEM.COMPOUND:123315041


subject: CHEBI:35218

subject_name: anthocyanin cation

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:35218

object_name: metabolic syndrome X


subject: CHEBI:36121

subject_name: flavylium


subject: CHEBI:36121


subject: CHEBI:40574

subject_name: acetyl group


subject: CHEBI:40574


subject: CHEBI:33337

subject_name: Actinium


subject: CHEBI:33337


subject: CHEBI:157787

subject_name: Ala-Cys


subject: CHEBI:157787


subject: PR:000004336

subject_name: acid ceramidase


subject: PR:000004336


subject: UNII:01KC87F8FE


subject: UNII:01KC87F8FE


subject: PR:000010011

subject_name: lysosomal-trafficking regulator


subject: PR:000010011


subject: PR:000003655


subject: PR:000003655


subject: UMLS:C2607565


subject: UMLS:C3854073

subject_name: Capsaicin 8% patch, per square centimeter

object_name: peripheral nervous system disorder


subject: UMLS:C3854073


subject: UMLS:C4087034

subject_name: Spleen Tyrosine Kinase Inhibitor HMPL-523

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C2703114

object_name: small cell lung carcinoma


subject: UMLS:C3640210

subject_name: Iobenguane I-124

object_name: Disseminated neuroblastoma


subject: UMLS:C3640210

object_name: Metastatic Neuroblastoma


subject: UMLS:C3640210

object_name: Stage 4S neuroblastoma


subject: UNII:G9WJT6RD29

subject_name: Burosumab

object_name: polyostotic fibrous dysplasia


subject: UNII:G9WJT6RD29

object_name: McCune-Albright syndrome


subject: UNII:G9WJT6RD29

object_name: fibrous dysplasia


subject: UMLS:C3896830


subject: UMLS:C3896830


subject: UMLS:C3896830


subject: UMLS:C5704062

subject_name: Venlafaxine ER

object_name: endogenous depression


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Aggressive behavior


subject: CHEBI:31236

object_name: Aggression


subject: CHEBI:31236

object_name: oppositional defiant disorder


subject: CHEBI:31236

object_name: Attention deficit-hyperactivity


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:94534


subject: CHEBI:94534


subject: CHEBI:94534


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:15407

subject_name: Ephedrine

object_name: Labor Pain


subject: CHEMBL.COMPOUND:CHEMBL2134724

subject_name: IPRATROPIUM BROMIDE

object_name: Depressed mood


subject: CHEMBL.COMPOUND:CHEMBL2134724

object_name: Cancer patients and suicide and depression


subject: CHEMBL.COMPOUND:CHEMBL2134724

object_name: Depressed - symptom


subject: CHEMBL.COMPOUND:CHEMBL2134724

object_name: Depression, CTCAE


subject: CHEBI:5957

subject_name: ipratropium bromide hydrate


subject: CHEBI:5957


subject: CHEBI:5957


subject: CHEBI:5957


subject: PUBCHEM.COMPOUND:3021749


subject: PUBCHEM.COMPOUND:3021749


subject: PUBCHEM.COMPOUND:3021749


subject: PUBCHEM.COMPOUND:3021749


subject: UNII:J697UZ2A9J


subject: UNII:J697UZ2A9J


subject: UNII:J697UZ2A9J


subject: UNII:J697UZ2A9J


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: PUBCHEM.COMPOUND:657309


subject: PUBCHEM.COMPOUND:657309


subject: PUBCHEM.COMPOUND:657309


subject: UMLS:C5706445

subject_name: RAS Inhibitor RMC-6236

object_name: digestive system cancer


subject: UMLS:C5706445

object_name: colorectal cancer


subject: UMLS:C5706445

object_name: colorectal carcinoma


subject: UMLS:C5706445

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C5706445

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:168201327


subject: PUBCHEM.COMPOUND:168201327


subject: PUBCHEM.COMPOUND:168201327


subject: PUBCHEM.COMPOUND:168201327


subject: PUBCHEM.COMPOUND:168201327


subject: PUBCHEM.COMPOUND:168201327

object_name: Matthew-Wood syndrome


subject: UMLS:C5907933

subject_name: KRAS G12D Inhibitor RMC-9805


subject: UMLS:C5907933


subject: UMLS:C5907933


subject: UMLS:C5907933


subject: UMLS:C5907933


subject: UMLS:C5907933


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UNII:PQX0D8J21J


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: periodontal disorder


subject: UNII:1C6V77QF41

object_name: periodontitis


subject: UNII:1C6V77QF41

object_name: Periodontal Disease, CTCAE


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Adult Central Nervous System Neoplasm


subject: UNII:DPT0O3T46P

object_name: Childhood Central Nervous System Neoplasm


subject: UNII:DPT0O3T46P

object_name: central nervous system neoplasm


subject: UNII:DPT0O3T46P

object_name: central nervous system cancer


subject: UNII:DPT0O3T46P

object_name: Malignant neoplasm of the central nervous system


subject: UNII:DPT0O3T46P

object_name: extranodal nasal NK/T cell lymphoma


subject: CHEBI:4875

subject_name: Etanercept

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:4875

object_name: vitiligo


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: retinoblastoma


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:44915

subject_name: Propofol

object_name: Cervical spondylosis without myelopathy


subject: CHEBI:44915

object_name: Neck Arthritis


subject: CHEBI:44915

object_name: osteoarthritis, knee


subject: CHEBI:44915

object_name: osteoarthritis, hip


subject: CHEBI:44915

object_name: Lumbar spondylosis


subject: CHEBI:232540

object_name: ovarian cancer


subject: CHEBI:232540

object_name: ovarian neoplasm


subject: UMLS:C4086591

subject_name: MnSOD Mimetic BMX-001


subject: UMLS:C4086591


subject: CHEMBL.COMPOUND:CHEMBL4297271


subject: CHEMBL.COMPOUND:CHEMBL4297271


subject: CHEBI:52717

subject_name: Bortezomib

object_name: neuromyelitis optica


subject: CHEBI:7852

subject_name: Oxycodone

object_name: sleep apnea


subject: CHEBI:7852

object_name: Sleep Apnea, CTCAE


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:135983

subject_name: Teriparatide

object_name: Pelvis fracture


subject: CHEBI:135307

subject_name: Moxaverine

object_name: macular degeneration


subject: CHEBI:135307

object_name: age-related macular degeneration


subject: CHEBI:135307

object_name: retinitis pigmentosa 30


subject: CHEBI:135307

object_name: glaucoma


subject: CHEBI:135307

object_name: Glaucoma, CTCAE


subject: UMLS:C0772257

subject_name: fruit extracts

object_name: Inflammation


subject: MESH:D013024

subject_name: Soybean Oil


subject: CHEBI:166975

subject_name: soybean oil


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:9241

object_name: Heart failure NYHA class II


subject: CHEBI:9241

object_name: Heart failure NYHA class IV


subject: CHEBI:9241

object_name: Heart failure NYHA class III


subject: CHEBI:231616

subject_name: gartisertib

object_name: Childhood Breast Carcinoma


subject: CHEBI:231616

object_name: breast carcinoma


subject: CHEBI:231616

object_name: breast cancer


subject: CHEBI:231616

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5206912


subject: UMLS:C5206912


subject: UMLS:C5206912


subject: UMLS:C5206912


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: testicular germ cell tumor 1


subject: PUBCHEM.COMPOUND:43805

object_name: testicular germ cell tumor


subject: PUBCHEM.COMPOUND:43805

object_name: childhood testicular germ cell tumor


subject: PUBCHEM.COMPOUND:43805

object_name: extragonadal germ cell tumor


subject: PUBCHEM.COMPOUND:43805

object_name: Childhood Teratoma


subject: PUBCHEM.COMPOUND:43805

object_name: adult teratoma


subject: PUBCHEM.COMPOUND:43805

object_name: teratoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:137262

subject_name: Leu-Asn-Ser

object_name: Child Malnutrition


subject: UMLS:C4763587

subject_name: Immunomodulatory IMiD Drugs

object_name: Childhood Solid Neoplasm


subject: UMLS:C4763587

object_name: Adult Solid Neoplasm


subject: UMLS:C4763587

object_name: Solid Neoplasm


subject: UMLS:C4763587

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:94622


subject: CHEBI:94622


subject: CHEBI:94622


subject: CHEBI:94622


subject: CHEBI:35498

subject_name: diuretic

object_name: ADHF


subject: UMLS:C0012798

subject_name: Diuretics


subject: CHEBI:5312

subject_name: gentamicin sulfate

object_name: urinary tract infection


subject: CHEBI:5312

object_name: Recurrent urinary tract infections


subject: CHEBI:5312

object_name: spinal cord disorder


subject: UNII:8X7386QRLV

subject_name: GENTAMICIN SULFATE


subject: UNII:8X7386QRLV


subject: UNII:8X7386QRLV


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: CHEBI:167655

object_name: childhood myelodysplastic syndrome


subject: CHEBI:167655

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:167655

object_name: Blast Phase


subject: CHEBI:167655

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:167655

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:167655

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:167655

object_name: Adult Acute Promyelocytic Leukemia


subject: CHEBI:167655

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:167655

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:167655

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:167655

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:167655

object_name: myelodysplastic syndrome with excess blasts


subject: UMLS:C5854501

subject_name: Anti-PD-L1/Anti-VEGF-A Bispecific Antibody PM8002

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:188218

object_name: seborrheic keratosis


subject: UMLS:C0608016


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Pulmonary aspiration during anaesthetic induction


subject: CHEBI:107736

object_name: obesity


subject: CHEBI:50648

subject_name: Alitretinoin

object_name: Childhood Breast Carcinoma


subject: CHEBI:50648

object_name: breast carcinoma


subject: CHEBI:50648

object_name: breast cancer


subject: CHEBI:50648

object_name: breast neoplasm


subject: UMLS:C5960912

subject_name: Anti-PD-1/Anti-TIGIT Bispecific Antibody ZG005

object_name: cervical cancer


subject: UMLS:C5960912

object_name: cervical carcinoma


subject: CHEBI:73024

subject_name: O-acetylcarnitine

object_name: hepatic encephalopathy


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: UNII:G2AE2VE07O

subject_name: Revefenacin

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:G2AE2VE07O

object_name: COPD, severe early onset


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: skin neoplasm


subject: UMLS:C5848866

object_name: skin cancer


subject: UMLS:C5848866

object_name: skin squamous cell carcinoma


subject: UMLS:C5848866

object_name: Autoimmunity


subject: UMLS:C5848866

object_name: trabecular adenocarcinoma


subject: UMLS:C5848866

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C5848866

object_name: basal cell carcinoma


subject: UMLS:C5848866

object_name: skin basal cell carcinoma


subject: MESH:C461320

subject_name: shosaiko-to

object_name: liver cancer


subject: MESH:C461320

object_name: liver neoplasm


subject: MESH:C461320

object_name: Adult Liver Carcinoma


subject: MESH:C461320

object_name: liver carcinoma


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:66919

object_name: aplastic anemia


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168

object_name: idiopathic aplastic anemia


subject: UMLS:C5706549

subject_name: Anti-PD-1/IL-2 Bispecific Antibody Fusion Protein IBI363

object_name: renal cell adenocarcinoma


subject: UMLS:C5706549

object_name: kidney cancer


subject: UMLS:C5706549

object_name: renal cell carcinoma


subject: UMLS:C5706549

object_name: childhood kidney cell carcinoma


subject: UMLS:C5706549

object_name: colorectal cancer


subject: UMLS:C5706549

object_name: colorectal carcinoma


subject: UMLS:C5706549

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1176021

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C1176021

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:55340

subject_name: morphine hydrochloride

object_name: Decreased liver function


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Infiltration


subject: UNII:7B2CS922HI

subject_name: DANICAMTIV

object_name: familial dilated cardiomyopathy


subject: DRUGBANK:DB18962

subject_name: Danicamtiv


subject: CHEBI:74698

subject_name: Met-Arg

object_name: Carotid Artery Plaque


subject: PR:000011407

subject_name: mineralocorticoid receptor


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: pancreatic neoplasm


subject: CHEBI:168396

object_name: exocrine pancreatic carcinoma


subject: CHEBI:168396

object_name: malignant pancreatic neoplasm


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: thyroid gland papillary carcinoma


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:135117

subject_name: ftivazide

object_name: Infection of transplanted kidney


subject: CHEBI:6030

subject_name: Isoniazid


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: chronic obstructive pulmonary disease


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:3392

subject_name: Carbendazim

object_name: diabetic foot


subject: CHEBI:168480

subject_name: Desoxylimonin


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Plasma cell myeloma refractory


subject: CHEBI:5801

object_name: Plasma cell myeloma recurrent


subject: UMLS:C4282370

subject_name: Progenta

object_name: uterine fibroid


subject: UMLS:C3540798

subject_name: Food allergenic extracts

object_name: Plasmodium falciparum malaria


subject: UMLS:C5555554

subject_name: Copper Cu 64-DOTA-TLX592

object_name: metastatic prostate carcinoma


subject: UMLS:C4279084

object_name: Parkinson disease


subject: CHEBI:7421

subject_name: NAC

object_name: Depressed mood


subject: CHEBI:7421

object_name: Cancer patients and suicide and depression


subject: CHEBI:7421

object_name: Depressed - symptom


subject: CHEBI:7421

object_name: Depression, CTCAE


subject: GTOPDB:8002

subject_name: bavituximab

object_name: neoplasm


subject: UNII:Q16CT95N25


subject: UMLS:C1707382


subject: GTOPDB:12349

subject_name: zimberelimab

object_name: childhood neoplasm


subject: GTOPDB:12349

object_name: neoplastic syndrome


subject: GTOPDB:12349

object_name: cancer or benign tumor


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: preeclampsia/eclampsia 1


subject: MESH:D002136

object_name: hypertension, pregnancy-induced


subject: MESH:D002136

object_name: HELLP syndrome


subject: MESH:D002136

object_name: Dietary calcium deficiency


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: CHEBI:6801

subject_name: Metformin

object_name: lipodystrophy


subject: CHEBI:8228

subject_name: Pioglitazone


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: rotator cuff syndrome


subject: PUBCHEM.COMPOUND:9848990

object_name: Rotator cuff tear


subject: PUBCHEM.COMPOUND:9848990

object_name: Rotator Cuff Injuries


subject: PUBCHEM.COMPOUND:9848990

object_name: Rotator Cuff Injury, CTCAE


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: UNII:234248D0HH

subject_name: Tucatinib

object_name: colorectal cancer


subject: UNII:234248D0HH

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:11511576

subject_name: Tedizolid phosphate

object_name: gram-positive bacterial infections


subject: CHEBI:82717

subject_name: Tedizolid


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: CHEBI:74327

subject_name: Ile-Val


subject: PUBCHEM.COMPOUND:54676860

object_name: Metastatic malignant neoplasm to pancreas


subject: PUBCHEM.COMPOUND:54676860

object_name: End stage cancer


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:22651

subject_name: ascorbate


subject: CHEBI:22651


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:167715

subject_name: L-ascorbic acid 2-sulfate


subject: CHEBI:167715


subject: UMLS:C2919980

subject_name: passiflora incarnata flowering top extract

object_name: Stress


subject: UMLS:C4059137

subject_name: Passiflora incarnata whole extract


subject: UMLS:C3495130

subject_name: Passiflora incarnata homeopathic preparation


subject: CHEMBL.COMPOUND:CHEMBL2109545

object_name: Solid Neoplasm


subject: UMLS:C2984207


subject: UNII:4A2Y23XK11

subject_name: Lazertinib

object_name: lung cancer


subject: UNII:4A2Y23XK11

object_name: lung neoplasm


subject: UNII:4A2Y23XK11

object_name: lung carcinoma


subject: UMLS:C0356365

subject_name: Insulin, Short-Acting

object_name: Intraoperative Complication


subject: UMLS:C5780016

subject_name: PD-L1/IDO Peptide Vaccine IO102-103

object_name: Unresectable Melanoma


subject: UMLS:C5780016

object_name: metastatic melanoma


subject: CHEBI:15727

subject_name: Carnosine

object_name: multiple sclerosis


subject: UMLS:C0007267

subject_name: carnosine


subject: CHEBI:24757

subject_name: Hypochlorite

object_name: Symptomatic irreversible pulpitis


subject: CHEBI:6801

subject_name: Metformin

object_name: Diabetes, Autoimmune


subject: UNII:4U7K5X4ANS

subject_name: Emeramide

object_name: mercury poisoning


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Metastatic non-small cell lung cancer


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:1391

subject_name: Midomafetamine

object_name: Moral Injury


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: melanoma


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: PUBCHEM.COMPOUND:155977629


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:52603


subject: GTOPDB:5019

subject_name: LPS


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: PR:000001155

subject_name: Toll-like receptor 4


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: oropharynx squamous cell carcinoma


subject: UMLS:C3896796

subject_name: narsoplimab

object_name: lupus nephritis


subject: UMLS:C3896796


subject: UMLS:C3896796

object_name: IgA nephropathy, susceptibility to, 1


subject: CHEMBL.COMPOUND:CHEMBL4298195

subject_name: NARSOPLIMAB


subject: CHEMBL.COMPOUND:CHEMBL4298195


subject: CHEMBL.COMPOUND:CHEMBL4298195

object_name: IgA Nephropathy


subject: CHEMBL.COMPOUND:CHEMBL4298195


subject: MESH:C000717093

object_name: chronic hepatitis B virus infection


subject: MESH:C000717093

object_name: hepatitis B


subject: UMLS:C0699619

subject_name: Nutropin

object_name: Androgen excess


subject: UMLS:C0754326

subject_name: Optison

object_name: Abdominal Neoplasms


subject: UMLS:C0754326

object_name: Pelvic Neoplasms


subject: UMLS:C4053489

subject_name: Fluorine F 18 Fluorthanatrace

object_name: Childhood Breast Carcinoma


subject: UMLS:C4053489

object_name: breast carcinoma


subject: UMLS:C4053489

object_name: breast cancer


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Chronic refractory cough


subject: UMLS:C4759829

object_name: non-small cell lung carcinoma


subject: UMLS:C4759829

object_name: lung cancer


subject: UMLS:C4759829

object_name: lung neoplasm


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox

object_name: plasma cell myeloma


subject: UMLS:C0211023


subject: UMLS:C0722264

subject_name: Ontak


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: autoimmune thrombocytopenia


subject: UNII:O43472U9X8

object_name: thrombocytopenia due to immune destruction


subject: UNII:O43472U9X8

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C5706466

subject_name: Cathepsin-targeted Fluorescent Imaging Probe VGT-309


subject: UMLS:C5706466


subject: UMLS:C5706466

object_name: lung carcinoma


subject: MESH:C570015

subject_name: 4CMenB vaccine

object_name: sexually transmitted disease


subject: MESH:C570015

object_name: gonorrhea


subject: CHEBI:9757

subject_name: Tropicamide

object_name: cataract


subject: CHEBI:9757

object_name: Cataract, CTCAE 3.0


subject: CHEBI:9757

object_name: Cataract, CTCAE 5.0


subject: CHEBI:9757

object_name: cataract on exam (physical finding)


subject: UMLS:C0721719

subject_name: Microlipid

object_name: necrotizing enterocolitis


subject: UMLS:C0721719

object_name: Necrotizing Enterocolitis, AE


subject: UMLS:C0721719

object_name: Small intestinal perforation


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: UMLS:C1174389

object_name: prostate adenocarcinoma


subject: CHEBI:135983

subject_name: Teriparatide

object_name: spinal cord injury


subject: CHEBI:45783

subject_name: Imatinib

object_name: Cervical spinal cord injury


subject: CHEBI:2181

subject_name: L-fucopyranose

object_name: Leukocyte adhesion deficiency


subject: CHEBI:2181

object_name: leukocyte adhesion deficiency 1


subject: CHEBI:48204

subject_name: Fucose


subject: CHEBI:48204


subject: CHEBI:42548

subject_name: alpha-L-fucose


subject: CHEBI:42548


subject: CHEBI:18287

subject_name: L-fucose


subject: CHEBI:18287


subject: CHEBI:18167

subject_name: alpha-maltose

object_name: apoplexy; brain


subject: CHEMBL.COMPOUND:CHEMBL2107951

subject_name: MALTODEXTRIN


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: follicular lymphoma


subject: CHEBI:79699

object_name: mantle cell lymphoma


subject: CHEBI:60787

subject_name: TIMOLOL

object_name: rosacea


subject: CHEBI:60787

object_name: acne


subject: CHEBI:39465

subject_name: timolol


subject: CHEBI:39465


subject: UNII:997WVV895X

subject_name: Rimegepant

object_name: Menstrual migraine


subject: CHEBI:40968

subject_name: Astaxanthin

object_name: Ametropia


subject: UMLS:C2985191

object_name: Myelodysplasia


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: liver disorder


subject: CHEBI:142431

subject_name: Praliciguat

object_name: Type 2 diabetes mellitus with established diabetic nephropathy


subject: UMLS:C5198199


subject: CHEBI:64073

object_name: Ischemic stroke


subject: CHEBI:46295

subject_name: Vardenafil

object_name: cystic fibrosis


subject: UMLS:C1258613

subject_name: oblimersen sodium

object_name: leukemia


subject: UMLS:C1258613

object_name: childhood leukemia


subject: DRUGBANK:DB05415

object_name: B-cell chronic lymphocytic leukemia


subject: GTOPDB:12652

subject_name: magrolimab

object_name: urothelial carcinoma


subject: GTOPDB:12652

object_name: transitional cell carcinoma


subject: GTOPDB:12652

object_name: bladder tumor


subject: GTOPDB:12652

object_name: urinary bladder carcinoma


subject: GTOPDB:12652

object_name: urinary bladder cancer


subject: GTOPDB:12652

object_name: childhood bladder carcinoma


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UNII:6XG22YQM2Z


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Recurrent Uterine Sarcoma


subject: CHEBI:31355

object_name: pseudomyxoma peritonei


subject: CHEBI:31355

object_name: Leydig cell tumor


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Cervix carcinoma recurrent


subject: CHEBI:175901

object_name: Vaginal cancer recurrent


subject: CHEBI:175901

object_name: Recurrent Vulvar Carcinoma


subject: CHEBI:175901


subject: CHEBI:175901

object_name: Recurrent Endometrial Cancer


subject: CHEBI:175901

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:175901


subject: CHEBI:175901

object_name: ovarian sarcoma


subject: CHEBI:175901


subject: UMLS:C4722722

subject_name: Oral Arsenic Trioxide Formulation

object_name: acute myeloid leukemia with mutated NPM1


subject: GTOPDB:9615

object_name: HIV infection


subject: CHEBI:90863

subject_name: Sonidegib

object_name: Plasma cell myeloma recurrent


subject: CHEBI:90863

object_name: Plasma cell myeloma refractory


subject: CHEBI:134709

subject_name: Pitolisant

object_name: pervasive developmental disorder


subject: CHEBI:134709

object_name: autism


subject: CHEBI:134709

object_name: autism spectrum disorder


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Fracture of posterior wall of acetabulum


subject: CHEBI:32307

subject_name: Zanamivir hydrate

object_name: influenza


subject: UMLS:C5688099


subject: CHEBI:601027

subject_name: Aliskiren

object_name: end stage renal failure


subject: CHEBI:135935

subject_name: Tapentadol

object_name: Congenital hallux valgus


subject: CHEBI:135935

object_name: Acquired hallux valgus


subject: CHEBI:135935

object_name: Arthralgia


subject: CHEBI:135935

object_name: Arthralgia, CTCAE


subject: CHEBI:9635

subject_name: Toremifene

object_name: female breast carcinoma


subject: UNII:KZ3DLD11RQ

object_name: pancreatic neoplasm


subject: UNII:KZ3DLD11RQ

object_name: exocrine pancreatic carcinoma


subject: UNII:KZ3DLD11RQ

object_name: malignant pancreatic neoplasm


subject: CHEBI:465284

subject_name: Ganciclovir

object_name: Cytomegalovirus viremia


subject: CHEBI:32599

object_name: magnesium measurement


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:135954

subject_name: Bilastine

object_name: Rhinoconjunctivitis


subject: UMLS:C3180953

object_name: generalized anxiety disorder


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: alcohol dependence


subject: CHEBI:2668

subject_name: Amlodipine

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:2668

object_name: metabolic syndrome X


subject: UMLS:C4733487

subject_name: PSA/PSMA/PSCA-encoding DNA Plasmid Vaccine PF-06755990

object_name: prostate cancer


subject: UMLS:C4733487

object_name: prostate neoplasm


subject: UMLS:C4733488

subject_name: AdC68 Expressing PSA/PSMA/PSCA Vaccine PF-06755992


subject: UMLS:C4733488


subject: UMLS:C4085978

subject_name: Anti-pd-1 checkpoint inhibitor pf-06801591


subject: UMLS:C4085978


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Acute lymphoblastic leukemia, in relapse


subject: CHEBI:70839

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:70839

object_name: Acute lymphoblastic leukemia with failed remission


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: UNII:353CX8CSHD

object_name: post operative nausea and vomiting


subject: CHEBI:45919

subject_name: TRIDECANOATE

object_name: Rett syndrome


subject: UMLS:C2348817

subject_name: Tridecanoic Acid


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: FGFR1 Gene Mutation


subject: UNII:Y6BX7BL23K

object_name: FGFR3 gene mutation


subject: UNII:Y6BX7BL23K

object_name: Unresectable Colorectal Carcinoma


subject: UNII:Y6BX7BL23K

object_name: Metastatic Colorectal Carcinoma


subject: UNII:Y6BX7BL23K

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UNII:Y6BX7BL23K

object_name: Stage III Colorectal Cancer AJCC v8


subject: UNII:Y6BX7BL23K

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: UNII:Y6BX7BL23K

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: UNII:Y6BX7BL23K

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: UNII:Y6BX7BL23K

object_name: Stage IIIC Colorectal Cancer AJCC v8


subject: UNII:Y6BX7BL23K

object_name: Stage IIIA Colorectal Cancer AJCC v8


subject: UNII:Y6BX7BL23K

object_name: Stage IIIB Colorectal Cancer AJCC v8


subject: UNII:Y6BX7BL23K

object_name: FGFR1 Gene Amplification


subject: UNII:Y6BX7BL23K

object_name: FGFR2 Gene Amplification


subject: UNII:Y6BX7BL23K

object_name: FGFR3 Gene Amplification


subject: UNII:Y6BX7BL23K

object_name: FGFR2 Gene Translocation


subject: UNII:Y6BX7BL23K

object_name: FGFR1 Gene Translocation


subject: UNII:Y6BX7BL23K

object_name: FGFR3 Gene Translocation